Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New care bundle aims to slash deadly gut disease in preterm babies

NCT ID NCT05934123

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at whether a set of guidelines called the EMNODN NEC Care Bundle helps very preterm babies (born before 32 weeks) get more of their own mother's milk and reduces a life-threatening gut condition called necrotising enterocolitis (NEC). Researchers will compare data from over 53,000 babies born in England and Wales before and after the bundle was introduced. The goal is to see if the bundle works and which parts are most helpful.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EMNODN NEC Care Bundle (a set of guidelines and support practices for neonatal units)
What this could lead to
If effective, this care bundle could help more preterm babies receive their mother's milk and lower the risk of a life-threatening gut disease called NEC.
What could go wrong
This is an observational study comparing before-and-after data, not a randomized trial, so other factors could explain any changes. The bundle may not work equally well in all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

53,600 people

The number who actually took part.

Started

Dec 2022

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will include all infants born at \<32 weeks gestational age who are admitted to a neonatal unit in England and Wales which contributes data to the National Neonatal Research Database (NNRD).

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All infants born at \<32 weeks' gestational age admitted for neonatal care in England and Wales between 01/01/2016 to 30/09/2023 and who survived at least 48 hours Exclusion criteria: * Infants whose data are not included in the National Neonatal Research Database (NNRD)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Necrotising enterocolitis neonatal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospitals of Derby and Burton NHS Foundation Trust

    Derby, Derbyshire, DE22 3DT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.